Avinger oct-guided technologies featured at amp 2021

Redwood city, ca / accesswire / august 16, 2021 / avinger, inc. (nasdaq:avgr), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of peripheral artery disease (pad), today announced presentations featuring the company's lumivascular, oct-guided, technologies at the annual amp (amputation prevention symposium) conference occurring last week. amp focuses on education and technologies for treating critical limb ischemia (cli), an advanced stage of pad, in patients facing a life-altering amputation.
AVGR Ratings Summary
AVGR Quant Ranking